Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized prospective study of three antiretroviral strategies in treatment‑naive HIV‑positive patients
2005-001164-32Phase 3Completed
- Sponsor
- Papa Giovanni XXIII Hospital
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in human immunodeficiency virus infection (HIV) comparing lamivudine + didanosine + efavirenz, lamivudine + didanosine + atazanavir/ritonavir and zidovudine + tenofovir disoproxil + efavirenz (3 arms). Started Aug 2007; status: completed.
02
Drugs
lamivudinedidanosineefavirenzatazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-001164-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001164-32.